Deep Value Reports

REGN Stock Risk & Deep Value Analysis

Regeneron Pharmaceuticals, Inc.

DVR Score

1.5

out of 10

Distressed

The Bottom Line on REGN

We analyzed Regeneron Pharmaceuticals, Inc. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran REGN through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Sep 5, 2025•Run Fresh Analysis →

REGN Deep Value Analysis

Regeneron is a high-quality, profitable pharmaceutical giant with robust R&D and strong market positions (e.g., Dupixent). However, its substantial current market capitalization (over $80B) and established, albeit growing, business model make 10x growth within 3-5 years highly improbable. Its catalysts, while significant for continued strong performance, are incremental rather than disruptive enough to generate such exponential returns from its large base, failing the '10x growth potential' criteria. It's a stable growth company, not an early-stage, high-risk, multi-bagger candidate.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More